发明名称 NOVEL COMPOUND, METHOD FOR MANUFACTURE OF THE SAME AND DRUG COMPOSITION CONTAINING THE SAME
摘要 A hybrid plasminogen activator which comprises the five kringle domains of plasminogen linked to the B-chain of t-PA or u-PA via an amino acid sequence comprising, respectively, the t-PA cleavage site between residues 275 and 276 and the cysteine residue 264 of t-PA or the u-PA cleavage site between residues 158 and 159 and the cysteine residue 148 of u-PA, or a derivative of a plasminogen activator comprising the serine protease domain of t-PA or u-PA, in which the catalytic site essential for plasminogen activator activity is blocked by a 2-aminobenzoyl group substituted in the 3- or 4-position with a halogen atom and optionally further substituted with one or more weakly electron-withdrawing or electon-donating groups, wherein the pseudo first order rate constant for hydrolysis of the derivative is in the range 6.0 x 10<-><5> to 4.0 x 10<-><4> sec<-><1> when measured in a buffer system consisting of 0.05M sodium phosphate, 0.1M sodium chloride, 0.01% v/v detergent comprising polyoxyethylenesorbitan monoleate having a molecular weight of approximately 1300, at pH 7.4 at 37 DEG C.
申请公布号 JPS6480287(A) 申请公布日期 1989.03.27
申请号 JP19880164086 申请日期 1988.06.30
申请人 BEECHAM GROUP PLC 发明人 MAIKERU JIYOSEFU BURAUN;JIEFURII HIYUU ROBINSON;RICHIYAADO ANTONII GOTSUDOUIN SUMISU;SAAKISU BARETSUTO KARINJIYAN
分类号 A61K38/46;A61K38/00;A61P7/02;C07C67/00;C07C239/00;C07C257/18;C07K1/113;C07K1/22;C07K14/00;C07K19/00;C12N9/64;C12N9/68;C12N9/72;C12N15/09;C12P21/02;C12R1/91 主分类号 A61K38/46
代理机构 代理人
主权项
地址